Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiora Pharmaceuticals (KPRX) Current Leases (2018 - 2025)

Kiora Pharmaceuticals' Current Leases history spans 8 years, with the latest figure at $164461.0 for Q4 2025.

  • For Q4 2025, Current Leases rose 604.18% year-over-year to $164461.0; the TTM value through Dec 2025 reached $164461.0, up 604.18%, while the annual FY2025 figure was $164461.0, 604.18% up from the prior year.
  • Current Leases reached $164461.0 in Q4 2025 per KPRX's latest filing, up from $155926.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $170056.0 in Q2 2021 to a low of $2503.0 in Q1 2021.
  • Average Current Leases over 5 years is $87250.4, with a median of $73289.0 recorded in 2023.
  • Peak YoY movement for Current Leases: skyrocketed 3588.25% in 2022, then plummeted 85.76% in 2023.
  • A 5-year view of Current Leases shows it stood at $118846.0 in 2021, then increased by 10.63% to $131482.0 in 2022, then crashed by 64.2% to $47069.0 in 2023, then tumbled by 50.38% to $23355.0 in 2024, then skyrocketed by 604.18% to $164461.0 in 2025.
  • Per Business Quant, the three most recent readings for KPRX's Current Leases are $164461.0 (Q4 2025), $155926.0 (Q3 2025), and $143327.0 (Q2 2025).